Published Online:13 Nov 2019https://doi.org/10.4155/ppa-2019-0024
References
- 1. Arrow Generics Limited & Anor v Merck & Co, Inc. High Court of England and Wales 1900 (Pat) (2007). http://www.bailii.org/cgi-bin/format.cgi?doc=/ew/cases/EWHC/Patents/2007/1900.html&query=(Arrow)+AND+(Generics)Google Scholar
- 2. Samsung Bioepis UK Limited and Biogen IDEC Limited.Google Scholar
- 3. Fujifilm Kyowa Kirin Biologics Co, Ltd v AbbVie Biotechnology Ltd & Anor, England and Wales Court of Appeal Civ 1 (2017).Google Scholar
- 4. Fujifilm Kyowa Kirin Biologics Company Limited and othersv AbbVie Biotechnology Limited & Anor, Court of Appeal [2017] EWCA Civ 1 (2007). http://www.bailii.org/cgi-bin/format.cgi?doc=/ew/cases/EWCA/Civ/2017/1.html&query=(abbvie)Google Scholar
- 5. See paragraphs [343] – [358] of the judgment. http://www.bailii.org/ew/cases/EWHC/Patents/2017/395.html#para343Google Scholar
- 6. This was notwithstanding that, earlier in December 2016, Henry Carr J had held at the interim stage that there was a real prospect that at trial a judge would grant the declarations sought, see High Court of England and Wales 3383 (Ch) (2016). http://www.bailii.org/cgi-bin/format.cgi?doc=/ew/cases/EWHC/Ch/2016/3383.html&query=(abbvie)Crossref, Google Scholar
- 7. Fujifilm Kyowa Kirin Biologics Company Limited and Others v AbbVie Biotechnology Limited High Court of England and Wales 395 (Pat) (2017). http://www.bailii.org/cgi-bin/format.cgi?doc=/ew/cases/EWHC/Patents/2017/395.html&query=(abbvie)Google Scholar
- 8. High Court of England and Wales 1520 (Pat) (2017). http://www.bailii.org/cgi-bin/format.cgi?doc=/ew/cases/EWHC/Patents/2019/1520.html&query=(pfizer)Google Scholar
